These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32756167)

  • 21. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress.
    Sinning C; Ojeda F; Zeller T; Zengin E; Rupprecht HJ; Lackner KJ; Bickel C; Blankenberg S; Schnabel RB; Westermann D
    Can J Cardiol; 2016 Dec; 32(12):1470-1477. PubMed ID: 27568502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations of novel cardiac biomarkers before and after hemodialysis session.
    Mueller T; Gegenhuber A; Kronabethleitner G; Leitner I; Haltmayer M; Dieplinger B
    Clin Biochem; 2015 Nov; 48(16-17):1163-6. PubMed ID: 26232288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between volume overload, chronic inflammation, and left ventricular dysfunction in chronic kidney disease patients.
    Hassan MO; Duarte R; Dix-Peek T; Vachiat A; Naidoo S; Dickens C; Grinter S; Manga P; Naicker S
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):131-135. PubMed ID: 27509588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patients.
    Molvin J; Jujic A; Bachus E; Gallo W; Tasevska-Dinevska G; Holm H; Melander O; Fedorowski A; Magnusson M
    ESC Heart Fail; 2019 Oct; 6(5):992-999. PubMed ID: 31339668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of NT-proBNP, proANP and novel biomarkers: copeptin and proadrenomedullin with LVEF and NYHA in patients with ischemic CHF, non-ischemic CHF and arterial hypertension.
    Vondráková D; Málek F; Ošťádal P; Vránová J; Miroslav P; Schejbalová M; Neužil P
    Int J Cardiol; 2011 Aug; 150(3):343-4. PubMed ID: 21640398
    [No Abstract]   [Full Text] [Related]  

  • 27. Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.
    O'Donoghue ML; Morrow DA; Cannon CP; Jarolim P; Desai NR; Sherwood MW; Murphy SA; Gerszten RE; Sabatine MS
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How does volume status affect BNP and troponin levels as markers of cardiovascular status in peritoneal dialysis?
    Garg R; Singh A; Khaja A; Martin A; Aggarwal K
    Congest Heart Fail; 2009; 15(5):240-4. PubMed ID: 19751426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients.
    Ludka O; Spinar J; Tomandl J; Konecny T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):325-30. PubMed ID: 23154540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
    Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between fluid status as assessed by bioimpedance analysis and NT-pro BNP, blood pressure and left ventricular mass index in hemodialysis patients.
    Yilmaz Z; Yildirim Y; Aydin FY; Aydin E; Kadiroglu AK; Yilmaz ME; Ulgen MS; Yildiz A
    Clin Ter; 2014; 165(1):e52-8. PubMed ID: 24589961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke.
    Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B
    Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotyping progression of secondary mitral regurgitation in chronic systolic heart failure.
    Arfsten H; Bartko PE; Pavo N; Heitzinger G; Mascherbauer J; Hengstenberg C; Hülsmann M; Goliasch G
    Eur J Clin Invest; 2019 Nov; 49(11):e13159. PubMed ID: 31356682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of volume overload by bioelectrical impedance analysis, NT-proBNP and inferior vena cava diameter in patients with stage 3&4 and 5 chronic kidney disease.
    Yilmaz Z; Yildirim Y; Oto F; Aydin FY; Aydin E; Kadiroglu AK; Yilmaz ME
    Ren Fail; 2014 May; 36(4):495-501. PubMed ID: 24456050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical application value of the plasma copeptin level in the assessment of heart failure with reduced left ventricular ejection fraction: A cross-sectional study.
    Xu L; Liu X; Wu S; Gai L
    Medicine (Baltimore); 2018 Sep; 97(39):e12610. PubMed ID: 30278578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study.
    Nah EH; Kim SY; Cho S; Kim S; Cho HI
    BMJ Open; 2019 Apr; 9(4):e026030. PubMed ID: 31005928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of residual renal function in peritoneal dialysis.
    Sikorska D; Pawlaczyk K; Olewicz-Gawlik A; Czepulis N; Posnik B; Baum E; Wanic-Kossowska M; Lindholm B; Oko A
    Int Urol Nephrol; 2016 Dec; 48(12):2101-2108. PubMed ID: 27734218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.